{
  "study_id": "NCT00596830",
  "study_title": "Randomized, Phase III Trial of First-Line Figitumumab in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone in Patients With Advanced Non-Small-Cell Lung Cancer",
  "table_name": "Table 1",
  "table_title": "Baseline Patient Characteristics",
  "description": "NOTE. Data are presented for all patients by randomized arm. The stratification factors (histology, sex, and adjuvant chemotherapy) are presented as collected in the case report forms rather than as collected by the randomization system.",
  "footnotes": [
    "Abbreviation: ECOG, Eastern Cooperative Oncology Group.",
    "*TNM Classification of Malignant Tumours (6th ed).11",
    "†Systemic therapy included carboplatin/paclitaxel (n = 3), cisplatin/vinorelbine (n = 7), cisplatin/gemcitabine (n = 4), carboplatin/gemcitabine (n = 3), cisplatin/etoposide (n = 3), other regimens with carboplatin (n = 3), other regimens with cisplatin (n = 4), and other nonplatinum regimens (n = 2)."
  ],
  "groups": [
    {
      "name": "Figitumumab Arm",
      "n": 342,
      "type": "investigational"
    },
    {
      "name": "Control Arm",
      "n": 339,
      "type": "control"
    }
  ],
  "characteristics": [
    {
      "original_label": "Sex",
      "standardized_name": "Sex",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Figitumumab Arm",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Control Arm",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "Male",
      "standardized_name": "Male Sex",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Sex",
      "group_data": [
        {
          "group_name": "Figitumumab Arm",
          "data_type": "categorical_count_percentage",
          "count": 261.0,
          "percentage": 76.0,
          "raw_string": "261 | 76"
        },
        {
          "group_name": "Control Arm",
          "data_type": "categorical_count_percentage",
          "count": 260.0,
          "percentage": 77.0,
          "raw_string": "260 | 77"
        }
      ]
    },
    {
      "original_label": "Female",
      "standardized_name": "Female Sex",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Sex",
      "group_data": [
        {
          "group_name": "Figitumumab Arm",
          "data_type": "categorical_count_percentage",
          "count": 81.0,
          "percentage": 24.0,
          "raw_string": "81 | 24"
        },
        {
          "group_name": "Control Arm",
          "data_type": "categorical_count_percentage",
          "count": 79.0,
          "percentage": 23.0,
          "raw_string": "79 | 23"
        }
      ]
    },
    {
      "original_label": "Age, years",
      "standardized_name": "Age",
      "unit": "years",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Figitumumab Arm",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Control Arm",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "Median",
      "standardized_name": "Age Median",
      "unit": "years",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Age, years",
      "group_data": [
        {
          "group_name": "Figitumumab Arm",
          "data_type": "numeric_single",
          "value": 62.0,
          "raw_string": "62"
        },
        {
          "group_name": "Control Arm",
          "data_type": "numeric_single",
          "value": 62.0,
          "raw_string": "62"
        }
      ]
    },
    {
      "original_label": "Range",
      "standardized_name": "Age Range",
      "unit": "years",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Age, years",
      "group_data": [
        {
          "group_name": "Figitumumab Arm",
          "data_type": "numeric_mean_range",
          "range_min": 30.0,
          "range_max": 90.0,
          "raw_string": "30-90"
        },
        {
          "group_name": "Control Arm",
          "data_type": "numeric_mean_range",
          "range_min": 36.0,
          "range_max": 83.0,
          "raw_string": "36-83"
        }
      ]
    },
    {
      "original_label": "Ethnicity",
      "standardized_name": "Ethnicity",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Figitumumab Arm",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Control Arm",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "White",
      "standardized_name": "White Race/Ethnicity",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Ethnicity",
      "group_data": [
        {
          "group_name": "Figitumumab Arm",
          "data_type": "categorical_count_percentage",
          "count": 265.0,
          "percentage": 78.0,
          "raw_string": "265 | 78"
        },
        {
          "group_name": "Control Arm",
          "data_type": "categorical_count_percentage",
          "count": 270.0,
          "percentage": 80.0,
          "raw_string": "270 | 80"
        }
      ]
    },
    {
      "original_label": "Asian",
      "standardized_name": "Asian Race/Ethnicity",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Ethnicity",
      "group_data": [
        {
          "group_name": "Figitumumab Arm",
          "data_type": "categorical_count_percentage",
          "count": 56.0,
          "percentage": 16.0,
          "raw_string": "56 | 16"
        },
        {
          "group_name": "Control Arm",
          "data_type": "categorical_count_percentage",
          "count": 59.0,
          "percentage": 17.0,
          "raw_string": "59 | 17"
        }
      ]
    },
    {
      "original_label": "Black",
      "standardized_name": "Black Race/Ethnicity",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Ethnicity",
      "group_data": [
        {
          "group_name": "Figitumumab Arm",
          "data_type": "categorical_count_percentage",
          "count": 9.0,
          "percentage": 3.0,
          "raw_string": "9 | 3"
        },
        {
          "group_name": "Control Arm",
          "data_type": "categorical_count_percentage",
          "count": 4.0,
          "percentage": 1.0,
          "raw_string": "4 | 1"
        }
      ]
    },
    {
      "original_label": "Other",
      "standardized_name": "Other Race/Ethnicity",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Ethnicity",
      "group_data": [
        {
          "group_name": "Figitumumab Arm",
          "data_type": "categorical_count_percentage",
          "count": 12.0,
          "percentage": 4.0,
          "raw_string": "12 | 4"
        },
        {
          "group_name": "Control Arm",
          "data_type": "categorical_count_percentage",
          "count": 6.0,
          "percentage": 2.0,
          "raw_string": "6 | 2"
        }
      ]
    },
    {
      "original_label": "ECOG performance status",
      "standardized_name": "ECOG Performance Status",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Figitumumab Arm",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Control Arm",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "0",
      "standardized_name": "ECOG Performance Status 0",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "ECOG performance status",
      "group_data": [
        {
          "group_name": "Figitumumab Arm",
          "data_type": "categorical_count_percentage",
          "count": 113.0,
          "percentage": 33.0,
          "raw_string": "113 | 33"
        },
        {
          "group_name": "Control Arm",
          "data_type": "categorical_count_percentage",
          "count": 115.0,
          "percentage": 34.0,
          "raw_string": "115 | 34"
        }
      ]
    },
    {
      "original_label": "1",
      "standardized_name": "ECOG Performance Status 1",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "ECOG performance status",
      "group_data": [
        {
          "group_name": "Figitumumab Arm",
          "data_type": "categorical_count_percentage",
          "count": 226.0,
          "percentage": 66.0,
          "raw_string": "226 | 66"
        },
        {
          "group_name": "Control Arm",
          "data_type": "categorical_count_percentage",
          "count": 217.0,
          "percentage": 64.0,
          "raw_string": "217 | 64"
        }
      ]
    },
    {
      "original_label": "Not reported",
      "standardized_name": "ECOG Performance Status Not Reported",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "ECOG performance status",
      "group_data": [
        {
          "group_name": "Figitumumab Arm",
          "data_type": "categorical_count_percentage",
          "count": 3.0,
          "percentage": 1.0,
          "raw_string": "3 | 1"
        },
        {
          "group_name": "Control Arm",
          "data_type": "categorical_count_percentage",
          "count": 7.0,
          "percentage": 2.0,
          "raw_string": "7 | 2"
        }
      ]
    },
    {
      "original_label": "Current disease stage*",
      "standardized_name": "Disease Stage",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Figitumumab Arm",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Control Arm",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "Stage IIIB",
      "standardized_name": "Stage IIIB Disease",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Current disease stage*",
      "group_data": [
        {
          "group_name": "Figitumumab Arm",
          "data_type": "categorical_count_percentage",
          "count": 39.0,
          "percentage": 11.0,
          "raw_string": "39 | 11"
        },
        {
          "group_name": "Control Arm",
          "data_type": "categorical_count_percentage",
          "count": 39.0,
          "percentage": 12.0,
          "raw_string": "39 | 12"
        }
      ]
    },
    {
      "original_label": "Stage IV",
      "standardized_name": "Stage IV Disease",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Current disease stage*",
      "group_data": [
        {
          "group_name": "Figitumumab Arm",
          "data_type": "categorical_count_percentage",
          "count": 302.0,
          "percentage": 88.0,
          "raw_string": "302 | 88"
        },
        {
          "group_name": "Control Arm",
          "data_type": "categorical_count_percentage",
          "count": 300.0,
          "percentage": 88.0,
          "raw_string": "300 | 88"
        }
      ]
    },
    {
      "original_label": "Not reported",
      "standardized_name": "Disease Stage Not Reported",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Current disease stage*",
      "group_data": [
        {
          "group_name": "Figitumumab Arm",
          "data_type": "categorical_count_percentage",
          "count": 1.0,
          "raw_string": "1 | < 1",
          "notes": "Percentage is <1"
        },
        {
          "group_name": "Control Arm",
          "data_type": "categorical_count_percentage",
          "count": 0.0,
          "raw_string": "0"
        }
      ]
    },
    {
      "original_label": "Smoking status",
      "standardized_name": "Smoking Status",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Figitumumab Arm",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Control Arm",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "Never smoked",
      "standardized_name": "Never Smoked",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Smoking status",
      "group_data": [
        {
          "group_name": "Figitumumab Arm",
          "data_type": "categorical_count_percentage",
          "count": 34.0,
          "percentage": 10.0,
          "raw_string": "34 | 10"
        },
        {
          "group_name": "Control Arm",
          "data_type": "categorical_count_percentage",
          "count": 33.0,
          "percentage": 10.0,
          "raw_string": "33 | 10"
        }
      ]
    },
    {
      "original_label": "Current smoker",
      "standardized_name": "Current Smoker",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Smoking status",
      "group_data": [
        {
          "group_name": "Figitumumab Arm",
          "data_type": "categorical_count_percentage",
          "count": 142.0,
          "percentage": 42.0,
          "raw_string": "142 | 42"
        },
        {
          "group_name": "Control Arm",
          "data_type": "categorical_count_percentage",
          "count": 141.0,
          "percentage": 42.0,
          "raw_string": "141 | 42"
        }
      ]
    },
    {
      "original_label": "Former smoker",
      "standardized_name": "Former Smoker",
      "category": "Demographics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Smoking status",
      "group_data": [
        {
          "group_name": "Figitumumab Arm",
          "data_type": "categorical_count_percentage",
          "count": 166.0,
          "percentage": 49.0,
          "raw_string": "166 | 49"
        },
        {
          "group_name": "Control Arm",
          "data_type": "categorical_count_percentage",
          "count": 165.0,
          "percentage": 49.0,
          "raw_string": "165 | 49"
        }
      ]
    },
    {
      "original_label": "Histology",
      "standardized_name": "Histology",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Figitumumab Arm",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Control Arm",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "Squamous cell",
      "standardized_name": "Squamous Cell Carcinoma",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Histology",
      "group_data": [
        {
          "group_name": "Figitumumab Arm",
          "data_type": "categorical_count_percentage",
          "count": 295.0,
          "percentage": 86.0,
          "raw_string": "295 | 86"
        },
        {
          "group_name": "Control Arm",
          "data_type": "categorical_count_percentage",
          "count": 289.0,
          "percentage": 85.0,
          "raw_string": "289 | 85"
        }
      ]
    },
    {
      "original_label": "Large cell",
      "standardized_name": "Large Cell Carcinoma",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Histology",
      "group_data": [
        {
          "group_name": "Figitumumab Arm",
          "data_type": "categorical_count_percentage",
          "count": 28.0,
          "percentage": 8.0,
          "raw_string": "28 | 8"
        },
        {
          "group_name": "Control Arm",
          "data_type": "categorical_count_percentage",
          "count": 26.0,
          "percentage": 8.0,
          "raw_string": "26 | 8"
        }
      ]
    },
    {
      "original_label": "Adenosquamous",
      "standardized_name": "Adenosquamous Carcinoma",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Histology",
      "group_data": [
        {
          "group_name": "Figitumumab Arm",
          "data_type": "categorical_count_percentage",
          "count": 15.0,
          "percentage": 4.0,
          "raw_string": "15 | 4"
        },
        {
          "group_name": "Control Arm",
          "data_type": "categorical_count_percentage",
          "count": 19.0,
          "percentage": 6.0,
          "raw_string": "19 | 6"
        }
      ]
    },
    {
      "original_label": "Other",
      "standardized_name": "Other Histology",
      "category": "Clinical Characteristics",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Histology",
      "group_data": [
        {
          "group_name": "Figitumumab Arm",
          "data_type": "categorical_count_percentage",
          "count": 4.0,
          "percentage": 1.0,
          "raw_string": "4 | 1"
        },
        {
          "group_name": "Control Arm",
          "data_type": "categorical_count_percentage",
          "count": 5.0,
          "percentage": 1.0,
          "raw_string": "5 | 1"
        }
      ]
    },
    {
      "original_label": "Prior treatments",
      "standardized_name": "Prior Treatments",
      "category": "Treatment History",
      "time_point": "Baseline",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Figitumumab Arm",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Control Arm",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "Surgery",
      "standardized_name": "Prior Surgery",
      "category": "Treatment History",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Prior treatments",
      "group_data": [
        {
          "group_name": "Figitumumab Arm",
          "data_type": "categorical_count_percentage",
          "count": 72.0,
          "percentage": 21.0,
          "raw_string": "72 | 21"
        },
        {
          "group_name": "Control Arm",
          "data_type": "categorical_count_percentage",
          "count": 61.0,
          "percentage": 18.0,
          "raw_string": "61 | 18"
        }
      ]
    },
    {
      "original_label": "Radiation",
      "standardized_name": "Prior Radiation Therapy",
      "category": "Treatment History",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Prior treatments",
      "group_data": [
        {
          "group_name": "Figitumumab Arm",
          "data_type": "categorical_count_percentage",
          "count": 44.0,
          "percentage": 13.0,
          "raw_string": "44 | 13"
        },
        {
          "group_name": "Control Arm",
          "data_type": "categorical_count_percentage",
          "count": 36.0,
          "percentage": 11.0,
          "raw_string": "36 | 11"
        }
      ]
    },
    {
      "original_label": "Adjuvant chemotherapy†",
      "standardized_name": "Prior Adjuvant Chemotherapy",
      "category": "Treatment History",
      "time_point": "Baseline",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Prior treatments",
      "group_data": [
        {
          "group_name": "Figitumumab Arm",
          "data_type": "categorical_count_percentage",
          "count": 14.0,
          "percentage": 4.0,
          "raw_string": "14 | 4"
        },
        {
          "group_name": "Control Arm",
          "data_type": "categorical_count_percentage",
          "count": 15.0,
          "percentage": 4.0,
          "raw_string": "15 | 4"
        }
      ]
    }
  ]
}